Armin Reitmair

Nesher Technologies (United States) — United States

Medicine · Health Sciences

16h-index2.3kcitations19works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genetic factors in colorectal cancer(10), Cancer Genomics and Diagnostics(8), Retinoids in leukemia and cellular processes(4), interferon and immune responses(3), Glaucoma and retinal disorders(2)

Publications19 total

Non-Coding RNAs: Functional Aspects and Diagnostic Utility in Oncology
International Journal of Molecular Sciences·2013· 44 citedOpen Access
Four-Color Alternating-Laser Excitation Single-Molecule Fluorescence Spectroscopy for Next-Generation Biodetection Assays
Clinical Chemistry·2012· 33 citedOpen Access
C6orf176: a novel possible regulator of cAMP-mediated gene expression
Physiological Genomics·2011· 26 cited
Prostaglandin E<sub>2</sub>receptor subtype EP2- and EP4-regulated gene expression profiling in human ciliary smooth muscle cells
Physiological Genomics·2010· 11 cited
Retinoid‐related molecule AGN193198 potently induces G<sub>2</sub>M arrest and apoptosis in bladder cancer cells
International Journal of Cancer·2005· 7 citedOpen Access
An antagonist of retinoic acid receptors more effectively inhibits growth of human prostate cancer cells than normal prostate epithelium
British Journal of Cancer·2004· 26 citedOpen Access
A Retinoid-Related Molecule that Does Not Bind to Classical Retinoid Receptors Potently Induces Apoptosis in Human Prostate Cancer Cells through Rapid Caspase Activation
Cancer Research·2004· 32 citedOpen Access
Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL
Nature Medicine·2001· 339 cited
The Absence of Msh2 Alters Abelson Virus Pre-B-Cell Transformation by Influencing <i>p53</i> Mutation
Molecular and Cellular Biology·2000· 8 citedOpen Access
MSH2-deficient murine lymphomas harbor insertion/deletion mutations in the transforming growth factor beta receptor type 2 gene and display low not high frequency microsatellite instability
Blood·2000· 24 cited
Tissues of MSH2-deficient mice demonstrate hypermutability on exposure to a DNA methylating agent
Proceedings of the National Academy of Sciences·1998· 76 cited
Female embryonic lethality in mice nullizygous for both Msh2 and p53
Nature Genetics·1997· 70 cited
Mutator phenotype in Msh2-deficient murine embryonic fibroblasts.
PubMed·1997· 64 cited
Base transitions dominate the mutational spectrum of a transgenic reporter gene in MSH2 deficient mice
Oncogene·1997· 67 cited
Defects of the Mismatch Repair Gene MSH2 Are Implicated in the Development of Murine and Human Lymphoblastic Lymphomas and Are Associated With the Aberrant Expression of Rhombotin-2 (Lmo-2) and Tal-1 (SCL)
Blood·1997· 80 citedOpen Access
Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice.
PubMed·1996· 165 cited
MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis.
PubMed·1996· 164 cited
The Tumor Suppressor Gene Brca1 Is Required for Embryonic Cellular Proliferation in the Mouse
Cell·1996· 665 citedOpen Access
MSH2 deficient mice are viable and susceptible to lymphoid tumours
Nature Genetics·1995· 382 cited

Frequent Co-authors

Tak W. Mak(10), Bharati Bapat(3), Mark Redston(3), Steven Gallinger(3), Richard Fishel(3), Roshantha A.S. Chandraratna(3), G. E. Brown(3), Andrew Wakeham(2), Matthew Bjerknes(2), Hazel Cheng(2), Kazy Hay(2), Robert Lowsky(2), John F. DeCoteau(2), Ryo Ichinohasama(2), Marshall E. Kadin(2), Susan E. Andrew(2), Margaret L. McKinnon(2), Agnes Francis(2), Frank R. Jirik(2), Teresa Wilson(2)